Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Susan L Hogan
Gleaning Relapse Risk From B Cell Phenotype: Decreased CD5+B Cells Portend a Shorter Time to Relapse After B Cell Depletion in Patients With ANCA-associated Vasculitis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Influence of Clinical and Demographic Variables on Mycophenolic Acid Pharmacokinetics in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Annals of Pharmacotherapy
Medicine
Pharmacology
Related publications
Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients With Renal ANCA-associated Vasculitis: Association With Risk to Relapse
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Clinical Characteristics of B-Cell Lymphoma-Associated Hemophagocytic Syndrome (B-Lahs): Comparison of CD5+ With CD5- B-Lahs.
Internal Medicine
Internal Medicine
Medicine
Molecular Landscape of Relapse/Refractory Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cd1d Regulates B Cell Development but Not B Cell Accumulation and IL10 Production in Mice With Pathologic CD5+ B Cell Expansion
BMC Immunology
Immunology
Clinical and Treatment-Related Features Determining the Risk of Late Relapse in Patients With Diffuse Large B-Cell Lymphoma
British Journal of Haematology
Hematology
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse
PLoS ONE
Multidisciplinary
Letter: Distinct Hepatitis B Virus Relapse Rates After Discontinuing Tenofovir and Entecavir Therapy in Chronic Hepatitis B Patients
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
